440 related articles for article (PubMed ID: 26141032)
1. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
[TBL] [Abstract][Full Text] [Related]
2. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
[TBL] [Abstract][Full Text] [Related]
3. New markers for predictions of acute and chronic rejection and graft outcomes in kidney transplant recipients; HLA-G gene 3'UTR 14 bp polymorphism and sHLA-G.
Darbas S; Yilmaz VT; Kocak H; Kisaoglu A; Demiryilmaz I; Aydinli B; Arslan HS; Ucar F
Gene; 2021 Jul; 790():145712. PubMed ID: 33984446
[TBL] [Abstract][Full Text] [Related]
4. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
[TBL] [Abstract][Full Text] [Related]
5. Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.
Okushi Y; Okino K; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
Clin Exp Nephrol; 2017 Oct; 21(5):932-940. PubMed ID: 28364323
[TBL] [Abstract][Full Text] [Related]
6. Soluble human leukocyte antigen-G (SHLA-G) in Tunisian kidney transplantation.
Bardi R; Sfar I; Aounallah-Skhiri H; Kallala C; Abderrahim E; Ben Abdallah T; Gorgi Y
Arch Inst Pasteur Tunis; 2011; 88(1-4):42-6. PubMed ID: 23461142
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen G and renal allograft transplant.
Farid E; Al-Wedaie F; Tabbara K; El-Agroudy AE; Al-Ghareeb SM
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():371-6. PubMed ID: 25894193
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Plasma Levels of Soluble HLA-G and HLA-G Genotypes in Kidney Transplant Recipients.
Piancatelli D; Maccarone D; Colanardi A; Sebastiani P; D'Anselmi F; Iesari S; Binda B; Pisani F
Transplant Proc; 2020 Jun; 52(5):1559-1561. PubMed ID: 32217007
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of sHLA-G-mediated with better graft acceptance in early posttransplantation.
Jin HL; Li CR; Xiao L; Shi BY; Cai M; Li ZL; Wang S; Chen LP; Zhan SL; Li PC
Transplant Proc; 2012 Jun; 44(5):1259-61. PubMed ID: 22663996
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA-G Polymorphisms in the 3'UTR Region and Soluble HLA-G with Kidney Graft Outcome.
Durmanova V; Bandzuchova H; Zilinska Z; Tirpakova J; Kuba D; Buc M; Polakova K
Immunol Invest; 2019 Aug; 48(6):644-658. PubMed ID: 31094243
[No Abstract] [Full Text] [Related]
11. HLA-G expression in the peripheral blood of live kidney transplant recipients.
Xiao L; Zhou WQ; Shi BY; Feng K; He XY; Wei YX; Gao Y; Meng XY; Xiao W
Chin Med J (Engl); 2013 Jul; 126(14):2652-5. PubMed ID: 23876890
[TBL] [Abstract][Full Text] [Related]
12. Association of high pretransplant sIL-6R plasma levels with acute tubular necrosis in kidney graft recipients.
Sadeghi M; Daniel V; Naujokat C; Mehrabi A; Opelz G
Transplantation; 2006 Jun; 81(12):1716-24. PubMed ID: 16794539
[TBL] [Abstract][Full Text] [Related]
13. Increased concentration of soluble human leukocyte antigen class I levels in the bronchoalveolar lavage of human pulmonary allografts.
Rizzo M; Sundaresan S; Lynch J; Trulock EP; Cooper J; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 1997 Nov; 16(11):1135-40. PubMed ID: 9402513
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy.
Blanco-García RM; López-Álvarez MR; Garrido IP; Salgado-Cecilia G; Campillo JA; Bolarín JM; Gimeno L; Muro M; García-Alonso AM; Martínez-Sánchez MV; Bernardo Pisa MV; Soriano-Díaz S; Pascual-Figal DA; Alvarez-López MR; Minguela A
Hum Immunol; 2013 Mar; 74(3):318-24. PubMed ID: 23247208
[TBL] [Abstract][Full Text] [Related]
15. Expression of HLA-G transcripts in graft biopsy samples of renal transplant recipients.
Žilinská Z; Bandžuchová H; Chrastina M; Trebatický B; Breza J; Handzušová M; Kuba D; Tirpáková J; Pavlechová M; Dedinská I; Rychlý B; Poláková K
Transpl Immunol; 2015 Nov; 33(3):159-65. PubMed ID: 26455418
[TBL] [Abstract][Full Text] [Related]
16. Urinary soluble HLA-DR is a potential biomarker for acute renal transplant rejection.
Ting YT; Coates PT; Marti HP; Dunn AC; Parker RM; Pickering JW; Jack RW; Kemp RA; Walker RJ; McLellan AD
Transplantation; 2010 May; 89(9):1071-8. PubMed ID: 20098353
[TBL] [Abstract][Full Text] [Related]
17. The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis.
Han F; Xiao W; Xu Y; Wu J; Wang Q; Wang H; Zhang M; Chen J
Nephrol Dial Transplant; 2008 Aug; 23(8):2666-72. PubMed ID: 18308769
[TBL] [Abstract][Full Text] [Related]
18. [Serum soluble HLA-G, soluble CD30 is correlated to the time after transplantation in renal transplant recipients].
Jin Z; Xu C; Duan W; Yang J; Tian P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):947-952. PubMed ID: 28712403
[TBL] [Abstract][Full Text] [Related]
19. The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance.
Hauer V; Risti M; Miranda BLM; da Silva JS; Cidral AL; Pozzi CM; Contieri FLC; Sadissou IA; Donadi EA; Augusto DG; Bicalho MDG
PLoS One; 2019; 14(2):e0212750. PubMed ID: 30794652
[TBL] [Abstract][Full Text] [Related]
20. Donor derived HLA-G polymorphisms have a significant impact on acute rejection in kidney transplantation.
Janssen M; Thaiss F; Nashan B; Koch M; Thude H
Hum Immunol; 2019 Mar; 80(3):176-183. PubMed ID: 30610894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
